Literature DB >> 11052502

Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells.

N Miyamoto1, Y Higuchi, M Tajima, M Ito, M Tsurudome, M Nishio, M Kawano, A Sudo, A Uchida, Y Ito.   

Abstract

Spindle-shaped cells were established from four giant-cell tumors of bone. When human blood monocytes were co-cultured with these cells, multinucleated giant-cell formation of monocytes was induced. Intriguingly, even when a filter (pore size: 0.45 microm) was interposed between monocytes and the spindle-shaped cells, polykaryocytes also appeared. These multinucleated giant cells were positive for tartrate-resistant acid phosphatase, expressed calcitonin receptor, and showed bone-resorption activity, characteristics of osteoclast-like cells. These findings indicate that soluble factors secreted from these cells play an important role in osteoclast-like cell formation from blood monocytes. These data additionally suggest that these cells support osteoclast-like cell formation in giant-cell tumors of bone. The cells also expressed mannose receptor, fibronectin, receptor activator of nuclear factorkappaB, and several cytokine mRNAs, including interleukin-6, receptor activator of nuclear factorkappaB ligand/osteoclast differentiation factor/osteoprotegerin ligand, and macrophage colony-stimulating factor. However, all of these molecules except receptor activator of nuclear factorkappaB ligand mRNA could also be detected in control HeLa and CV-1 cells. Although the soluble receptor activator of nuclear factorkappaB ligand has not been found under physiological conditions, it is possible that it is cleaved by cellular proteases and the truncated receptor activator of nuclear factorkappaB is released from cells. Identification of the soluble factors capable of inducing osteoclast formation from blood monocytes is a pressing problem to be solved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052502     DOI: 10.1002/jor.1100180418

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  13 in total

Review 1.  Giant cell tumor of bone.

Authors:  Alan W Yasko
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

2.  Collagenase expression and activity in the stromal cells from giant cell tumour of bone.

Authors:  Robert W Cowan; Isabella W Y Mak; Nigel Colterjohn; Gurmit Singh; Michelle Ghert
Journal:  Bone       Date:  2009-02-12       Impact factor: 4.398

3.  Histogenetic characterization of giant cell tumor of bone.

Authors:  Manuela Salerno; Sofia Avnet; Marco Alberghini; Armando Giunti; Nicola Baldini
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

4.  Role of the VEGF-Flt-1-FAK pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone.

Authors:  Yoshihiro Matsumoto; Yuko Okada; Jun-Ichi Fukushi; Satoshi Kamura; Toshifumi Fujiwara; Keiichiro Iida; Mihoko Koga; Shuichi Matsuda; Katsumi Harimaya; Akio Sakamoto; Yukihide Iwamoto
Journal:  J Orthop Surg Res       Date:  2010-11-09       Impact factor: 2.359

5.  Fibrous dysplasia and central giant cell granuloma: a report of hybrid lesion with its review and hypotheticated pathogenesis.

Authors:  Saritha Kurra; Sreenatha Reddy D; Sumanth Gunupati; Srikanth K; Srinath Reddy M
Journal:  J Clin Diagn Res       Date:  2013-05-01

Review 6.  Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.

Authors:  Yuhree Kim; Saqib Nizami; Hana Goto; Francis Y Lee
Journal:  Clin Orthop Surg       Date:  2012-05-17

7.  Giant cell tumor of the temporal bone--a case report.

Authors:  S Balaji Pai; R M Lalitha; Kavitha Prasad; Saraswathi G Rao; K Harish
Journal:  BMC Ear Nose Throat Disord       Date:  2005-09-15

8.  Recurrent case of central giant cell granuloma with multiple soft tissue involvement.

Authors:  Suresh Yadav; Anurag Singh; Prince Kumar; Shallu Tyagi
Journal:  Natl J Maxillofac Surg       Date:  2014-01

9.  Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.

Authors:  Osamu Dohi; Haruo Ohtani; Masahito Hatori; Elichi Sato; Masami Hosaka; Hiroshi Nagura; Eiji Itoi; Shoichi Kokubun
Journal:  Histopathology       Date:  2009-10       Impact factor: 5.087

10.  Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy.

Authors:  Matthew R Steensma; Wakenda K Tyler; Allison G Shaber; Steven R Goldring; F Patrick Ross; Bart O Williams; John H Healey; P Edward Purdue
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.